Today, PhRMA, The Partnership for Safe Medicines and Council for Affordable Health Coverage initiated litigation in the U.S. District Court for the District of Columbia challenging action by HHS and FDA permitting pharmacists and wholesalers, pursuant to state-sponsored programs, to import certain prescription drugs from Canada into the United States without drug manufacturers’ authorization or oversight.

[...]

On February 13, 2020 the Colorado Senate’s Health and Human Services Committee held a hearing during which a member of the committee asked where the $810,000 to implement drug importation has gone, and what the progress is. His questions, which are directed to head of the agency and the lead importation pharmacist, begin at 6:56.…

[...]

Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…

[...]